Relapsed Refractory Multiple Myeloma (RRMM) Clinical Trials in Seoul
3 recruitingSeoul, South Korea
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Relapsed Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals410 enrolled159 locationsNCT05730036
Recruiting
Phase 1Phase 2
Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma
Relapsed Refractory Multiple Myeloma (RRMM)
YOUNGIL KOH75 enrolled7 locationsNCT06645678
Recruiting
Phase 2
Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy
Relapsed Refractory Multiple Myeloma (RRMM)
Seoul National University Hospital40 enrolled1 locationNCT06920251